ClinicalTrials.Veeva

Menu

Adequacy of Perioperative Cefuroxime Dosage According to the BMI

U

Universitätsklinikum Hamburg-Eppendorf

Status and phase

Completed
Phase 4

Conditions

Obesity; Drug

Treatments

Drug: Cefuroxime 1,5g
Drug: Cefuroxime 4,5g
Drug: Cefuroxime 3g

Study type

Interventional

Funder types

Other

Identifiers

NCT03141476
AntibioticsCefuroximePV5153

Details and patient eligibility

About

This study evaluates the dosage of perioperative cefuroxime for obese patients. Dosage was increased if the BMI was over 30kg/m*m and as well over 50kg/m*m. Drug levels were measured in blood and tissue.

Full description

Cefuroxime is an often used antibiotic for surgery antibiotic prophylaxis to avoid surgical wound infection. In this study the dosage of cefuroxime was adjusted to the BMI:

less than 30kg/m*m: 1,5g 31-50kg/m*m: 3,0g more than 50kg/m*m: 4,5g

Cefuroxime was applicated 30 to 60 minutes before the begin of surgery. Drug Levels in blood and fat tissue were measured at skin cut (30-60 minutes after application of Cefuroxime), 45 minutes after skin cut (75-105 minutes after minutes after application of Cefuroxime) and at the end of surgery (up to 150 minutes after application of Cefuroxime) .

The hypothesis of this study is that adequate drug levels are reached in all groups.

Enrollment

60 patients

Sex

All

Ages

18 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • elective laparoscopic Intervention
  • BMI < 90 kg/m*m
  • age: 18-85 years

Exclusion criteria

  • known history of allergy to cefuroxime or other cephalosporines
  • absent consent skill
  • elective open surgery
  • preoperative therapy with antibiotics
  • patient's denial of the study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 3 patient groups

Cefuroxime 1,5g
Other group
Description:
BMI \<30kg/m\*m
Treatment:
Drug: Cefuroxime 1,5g
Cefuroxime 3g
Other group
Description:
BMI 30-50kg/m\*m
Treatment:
Drug: Cefuroxime 3g
Cefuroxime 4,5g
Other group
Description:
BMI \>50kg/m\*m
Treatment:
Drug: Cefuroxime 4,5g

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems